|Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology|
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
|Identification of a biological signature for schizophrenia in serum|
E Schwarz, PC Guest, H Rahmoune, LW Harris, L Wang, FM Leweke, ...
Molecular psychiatry 17 (5), 494-502, 2012
|Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene–environment interaction: objectives, sample characteristics, recruitment …|
N Korver, PJ Quee, HBM Boos, CJP Simons, L de Haan, ...
International journal of methods in psychiatric research 21 (3), 205-221, 2012
|Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia|
E Schwarz, R Izmailov, M Spain, A Barnes, JP Mapes, PC Guest, ...
Biomarker Insights 5, BMI. S4877, 2010
|Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients|
RC Drexhage, L van der Heul-Nieuwenhuijsen, RC Padmos, ...
International Journal of Neuropsychopharmacology 13 (10), 1369-1381, 2010
|An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro-and anti-inflammatory forces|
RC Drexhage, TA Hoogenboezem, D Cohen, MA Versnel, WA Nolen, ...
International Journal of Neuropsychopharmacology 14 (6), 746-755, 2011
|Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia|
PC Guest, E Schwarz, D Krishnamurthy, LW Harris, FM Leweke, ...
Psychoneuroendocrinology 36 (7), 1092-1096, 2011
|Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naive schizophrenia patients|
PC Guest, L Wang, LW Harris, K Burling, Y Levin, A Ernst, MT Wayland, ...
Molecular psychiatry 15 (2), 118-119, 2010
|Treatment adherence therapy in people with psychotic disorders: randomised controlled trial|
ABP Staring, M Van der Gaag, GT Koopmans, JP Selten, JM Van Beveren, ...
The British Journal of Psychiatry 197 (6), 448-455, 2010
|Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset|
MK Chan, MO Krebs, D Cox, PC Guest, RH Yolken, H Rahmoune, ...
Translational psychiatry 5 (7), e601-e601, 2015
|Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: a meta-analysis|
WP Hoen, JG Lijmer, M Duran, RJA Wanders, NJM van Beveren, ...
Psychiatry research 207 (1-2), 1-12, 2013
|AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder|
R Van Winkel, NJM Van Beveren, C Simons
Neuropsychopharmacology 36 (12), 2529-2537, 2011
|Physiological responsivity to emotional pictures in schizophrenia|
RJ Hempel, JHM Tulen, NJM van Beveren, HG van Steenis, PGH Mulder, ...
Journal of psychiatric research 39 (5), 509-518, 2005
|Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways|
E Schwarz, NJM van Beveren, J Ramsey, FM Leweke, M Rothermundt, ...
Schizophrenia bulletin 40 (4), 787-795, 2014
|High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls|
A Vreeker, MPM Boks, L Abramovic, S Verkooijen, AH van Bergen, ...
Psychological medicine 46 (4), 807-818, 2016
|Immune and neuroimmune alterations in mood disorders and schizophrenia|
RC Drexhage, K Weigelt, N van Beveren, D Cohen, MA Versnel, ...
International review of neurobiology 101, 169-201, 2011
|TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU. 1 as important transcription factors|
K Weigelt, LA Carvalho, RC Drexhage, A Wijkhuijs, H de Wit, ...
Brain, behavior, and immunity 25 (6), 1162-1169, 2011
|Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled …|
LJ van Nimwegen, L de Haan, NJM van Beveren, M van der Helm, ...
The Canadian Journal of Psychiatry 53 (6), 400-405, 2008
|The effect of antipsychotic medication on facial affect recognition in schizophrenia: a review|
RJ Hempel, JA Dekker, NJM van Beveren, JHM Tulen, MW Hengeveld
Psychiatry research 178 (1), 1-9, 2010
|Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis|
L van Nimwegen, L de Haan, N van Beveren, W Laan, W van den Brink, ...
Journal of clinical psychopharmacology 28 (2), 214-218, 2008